Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
22.94
-0.55 (-2.36%)
At close: Mar 17, 2026, 4:00 PM EDT
22.48
-0.45 (-1.98%)
After-hours: Mar 17, 2026, 6:31 PM EDT
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $195.26 million as of March 17, 2026. Its market cap has increased by 65.01% in one year.
Market Cap
195.26M
Enterprise Value
45.32M
1-Year Change
65.01%
Ranking
Category
Stock Price
$22.94
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $346.92M to $195.26M, a decrease of -43.72%. That is a compound annual growth rate of -7.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 375.85M | 281.31% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAB Biotherapeutics | 209.92M |
| Canton Strategic Holdings | 207.36M |
| NeOnc Technologies Holdings | 204.23M |
| Galectin Therapeutics | 203.73M |
| Acumen Pharmaceuticals | 202.92M |
| MacroGenics | 202.11M |
| Cartesian Therapeutics | 200.67M |
| Zentalis Pharmaceuticals | 199.77M |